Silicon Valley Capital Partners’s Sanofi SNY Stock Holding History

Silicon Valley Capital Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$723	Buy	+15	New	+$699	﹤0.01%	351

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Silicon Valley Capital Partners's SNY Position: Q1 2026 in Review

Silicon Valley Capital Partners opened a new position in Sanofi (SNY) in Q1 2026: 15 shares worth $723. The stake represents ﹤0.01% of the portfolio and ranks #351 among its holdings.

745 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Silicon Valley Capital Partners held 15 shares of Sanofi worth $723 as of Q1 2026.
Sanofi was a new Silicon Valley Capital Partners position in Q1 2026.
Sanofi made up ﹤0.01% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #351 holding.
745 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.